Shortly after the Supreme Court overturned Roe v. Wade, an application for Opill, an over-the-counter birth control medication was submitted to the FDA.
I explain the difference between this pill and other contraceptives, and how over-the-counter access could affect reproductive care across the U.S.
0:00 Women may now be able to access monthly oral contraceptives without a prescription
0:34 Estrogen vs. Progestin: what’s in these pills?
1:14 Estrogen vs. Progestin: bleeding patterns
1:50 Estrogen vs. Progestin: timing
2:33 Estrogen vs. Progestin: side effects and contraindications
3:19 Why does this matter?
I’m Daniela Hernandez, a health and science reporter for WSJ, and on this channel I’ll be covering a variety of subjects from neuroscience to the science of food and public health. If you’re interested in science and health and how cutting edge research impacts our lives, don’t forget to subscribe.
#BirthControl #RoevWade #DanielaHernandez
![](https://s2.save4k.ru/pic/2yVAPq2MP-c/maxresdefault.jpg)